These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Immunohistochemical expression of CD44 in oral squamous cell carcinoma in relation to histomorphological parameters and clinicopathological factors. Boxberg M; Götz C; Haidari S; Dorfner C; Jesinghaus M; Drecoll E; Boskov M; Wolff KD; Weichert W; Haller B; Kolk A Histopathology; 2018 Oct; 73(4):559-572. PubMed ID: 29468726 [TBL] [Abstract][Full Text] [Related]
6. ZEB1 promotes the progression and metastasis of cervical squamous cell carcinoma via the promotion of epithelial-mesenchymal transition. Ma Y; Zheng X; Zhou J; Zhang Y; Chen K Int J Clin Exp Pathol; 2015; 8(9):11258-67. PubMed ID: 26617850 [TBL] [Abstract][Full Text] [Related]
8. Subcellular localization and expression of E-cadherin and SNAIL are relevant since early stages of oral carcinogenesis. Lopes NM; Xavier FCA; Ortiz RC; Amôr NG; Garlet GP; Lara VS; Batista AC; Costa NL; Rodini CO Pathol Res Pract; 2018 Aug; 214(8):1185-1191. PubMed ID: 29970306 [TBL] [Abstract][Full Text] [Related]
9. Epithelial-Mesenchymal Transition during Metastasis of HPV-Negative Pharyngeal Squamous Cell Carcinoma. Ihler F; Gratz R; Wolff HA; Weiss BG; Bertlich M; Kitz J; Salinas G; Rave-Fränk M; Canis M Biomed Res Int; 2018; 2018():7929104. PubMed ID: 29693014 [TBL] [Abstract][Full Text] [Related]
10. Expression of E-cadherin and β-catenin in basaloid and conventional squamous cell carcinoma of the oral cavity: are potential prognostic markers? Hanemann JA; Oliveira DT; Nonogaki S; Nishimoto IN; de Carli ML; Landman G; Kowalski LP BMC Cancer; 2014 Jun; 14():395. PubMed ID: 24893577 [TBL] [Abstract][Full Text] [Related]
11. The upregulated α-catulin expression was involved in head-neck squamous cell carcinogenesis by promoting proliferation, migration, invasion, and epithelial to mesenchymal transition. Zhang Z; Yang XF; Huang KQ; Ren L; Zhao S; Gou WF; Shen DF; Sun HZ; Takano Y; Zheng HC Tumour Biol; 2016 Feb; 37(2):1671-81. PubMed ID: 26311049 [TBL] [Abstract][Full Text] [Related]
12. P120ctn may participate in epithelial-mesenchymal transition in OSCC. Zhong C; Zuo Z; Ji Q; Feng D Indian J Cancer; 2016; 53(1):20-4. PubMed ID: 27146732 [TBL] [Abstract][Full Text] [Related]
13. The prognostic role of the epithelial-mesenchymal transition markers E-cadherin and Slug in laryngeal squamous cell carcinoma. Cappellesso R; Marioni G; Crescenzi M; Giacomelli L; Guzzardo V; Mussato A; Staffieri A; Martini A; Blandamura S; Fassina A Histopathology; 2015 Oct; 67(4):491-500. PubMed ID: 25684546 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA-155-5p is associated with oral squamous cell carcinoma metastasis and poor prognosis. Baba O; Hasegawa S; Nagai H; Uchida F; Yamatoji M; Kanno NI; Yamagata K; Sakai S; Yanagawa T; Bukawa H J Oral Pathol Med; 2016 Apr; 45(4):248-55. PubMed ID: 26307116 [TBL] [Abstract][Full Text] [Related]
15. Expression of E-cadherin and vimentin in oral squamous cell carcinoma. Zhou J; Tao D; Xu Q; Gao Z; Tang D Int J Clin Exp Pathol; 2015; 8(3):3150-4. PubMed ID: 26045832 [TBL] [Abstract][Full Text] [Related]
16. The role of E-cadherin down-regulation in oral cancer: CDH1 gene expression and epigenetic blockage. Pannone G; Santoro A; Feola A; Bufo P; Papagerakis P; Lo Muzio L; Staibano S; Ionna F; Longo F; Franco R; Aquino G; Contaldo M; De Maria S; Serpico R; De Rosa A; Rubini C; Papagerakis S; Giovane A; Tombolini V; Giordano A; Caraglia M; Di Domenico M Curr Cancer Drug Targets; 2014; 14(2):115-27. PubMed ID: 24274398 [TBL] [Abstract][Full Text] [Related]
17. Prognostic and clinicopathological features of E-cadherin, alpha-catenin, beta-catenin, gamma-catenin and cyclin D1 expression in human esophageal squamous cell carcinoma. Lin YC; Wu MY; Li DR; Wu XY; Zheng RM World J Gastroenterol; 2004 Nov; 10(22):3235-9. PubMed ID: 15484291 [TBL] [Abstract][Full Text] [Related]
18. Molecular profiling of tumour budding implicates TGFβ-mediated epithelial-mesenchymal transition as a therapeutic target in oral squamous cell carcinoma. Jensen DH; Dabelsteen E; Specht L; Fiehn AM; Therkildsen MH; Jønson L; Vikesaa J; Nielsen FC; von Buchwald C J Pathol; 2015 Aug; 236(4):505-16. PubMed ID: 25925492 [TBL] [Abstract][Full Text] [Related]
19. Markers of epithelial to mesenchymal transition in association with survival in head and neck squamous cell carcinoma (HNSCC). Pectasides E; Rampias T; Sasaki C; Perisanidis C; Kouloulias V; Burtness B; Zaramboukas T; Rimm D; Fountzilas G; Psyrri A PLoS One; 2014; 9(4):e94273. PubMed ID: 24722213 [TBL] [Abstract][Full Text] [Related]
20. The prognostic role of E-cadherin and β-catenin overexpression in laryngeal squamous cell carcinoma. Greco A; De Virgilio A; Rizzo MI; Pandolfi F; Rosati D; de Vincentiis M Laryngoscope; 2016 Apr; 126(4):E148-55. PubMed ID: 26511677 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]